Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS)

Supportive Care in Cancer

Volumn 23, Issue 8, 2015, Pages 2341-2347

  LeBlanc, Thomas W ^a,b,c,e   Samsa, Greg P ^b   Wolf, Steven P ^b   Locke, Susan C ^b   Cella, David F ^d   Abernethy, Amy P ^a,b,c  

^a DUKE CANCER INSTITUTE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Division of Medical Oncology Department of Medicine Duke University School of Medicine ^*  (United States)

Author keywords

Cancer anorexia cachexia syndrome; Quality of life instruments; Validity

Indexed keywords

ADVANCED CANCER; AGED; ANOREXIA; APPETITE; ARTICLE; CACHEXIA; CANCER ANOREXIA CACHEXIA SYNDROME; CANCER ANOREXIA CACHEXIA SYNDROME SUBSCALE; CANCER PATIENT; CLINICAL RESEARCH; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF ANOREXIA CACHEXIA THERAPY SCALE; HUMAN; INTERNAL VALIDITY; KARNOFSKY PERFORMANCE STATUS; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; NUTRITIONAL ASSESSMENT; PATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; SELF REPORT; VALIDATION STUDY; WEIGHT REDUCTION; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; LONGITUDINAL STUDY; LUNG NEOPLASMS; MIDDLE AGED; QUALITY OF LIFE;

ANOREXIA; CACHEXIA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 84933179165     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2606-z     Document Type: Article

References (15)

1. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799. doi:10.1016/j.clnu.2008.06.013
2. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study G (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345–1350
3. George J, Cannon T, Lai V, Richey L, Zanation A, Hayes DN, Shores C, Guttridge D, Couch M (2007) Cancer cachexia syndrome in head and neck cancer patients: part II. Pathophysiology. Head Neck 29(5):497–507. doi:10.1002/hed.20630
4. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495. doi:10.1016/S1470-2045(10)70218-7
5. Couch M, Lai V, Cannon T, Guttridge D, Zanation A, George J, Hayes DN, Zeisel S, Shores C (2007) Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 29(4):401–411. doi:10.1002/hed.20447
6. LeBlanc TW, Nipp RD, Rushing CN, Samsa GP, Locke SC, Kamal AH, Cella D, Abernethy AP (2014) Correlation between the International Consensus Definition of the Cancer Anorexia Cachexia Syndrome (CACS) and Patient-Centered Outcomes in Advanced Non-small Cell Lung Cancer. J Pain Symptom Manag. doi:10.1016/j.jpainsymman.2014.09.008
7. Cella DF, Tulsky DS (1993) Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest 11(3):327–336
8. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579
9. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P (1995) Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12(3):199–220
10. Ribaudo JM, Cella D, Hahn EA, Lloyd SR, Tchekmedyian NS, Von Roenn J, Leslie WT (2000) Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9(10):1137–1146
11. Wheelwright S, Darlington AS, Hopkinson JB, Fitzsimmons D, White A, Johnson CD (2013) A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer 21(9):2625–2636. doi:10.1007/s00520-013-1881-9
12. Butt Z, Webster K, Eisenstein AR, Beaumont J, Eton D, Masters GA, Cella D (2005) Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment of Cancer Therapy-Lung scale. Hematol Oncol Clin North Am 19(2):389–420. doi:10.1016/j.hoc.2005.02.009, viii
13. Suh SY, Leblanc TW, Shelby RA, Samsa GP, Abernethy AP (2011) Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J Oncol Pract 7(6):374–381. doi:10.1200/JOP.2011.000434
14. Abernethy AP, Currow DC (2010) Need for mechanistically focused research of global systemic interventions in palliative care. J Pain Symptom Manag 40(3):e5–e8. doi:10.1016/j.jpainsymman.2010.06.006
15. Temel J, Currow DC, Fearon K, Gleich L, Yan Y, Friend J, Abernethy AP (2014) Anamorelin for the treatment of cancer anorexia-cachexia in NSCLC: Results from the phase 3 studies ROMANA 1 and 2. Paper presented at the European Society of Medical Oncology, Madrid, 2014